KMT2C Rekombinanter Antikörper

KMT2C Rekombinant Antikörper für IF/ICC, FC (Intra), ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

IF/ICC, FC (Intra), ELISA

Konjugation

Unkonjugiert

CloneNo.

240542A2

Kat-Nr. : 83595-4-PBS

Synonyme

MLL3, 240542A2, HALR, Homologous to ALR protein, KIAA1506



Geprüfte Anwendungen

Produktinformation

83595-4-PBS bindet in IF/ICC, FC (Intra), ELISA KMT2C und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen KMT2C fusion protein Ag28875
Vollständiger Name myeloid/lymphoid or mixed-lineage leukemia 3
Berechnetes Molekulargewicht 541 kDa
GenBank-ZugangsnummerNM_170606
Gene symbol KMT2C
Gene ID (NCBI) 58508
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Lysine (K)-specific methyltransferase 2C (KMT2C, also known as MLL3) belongs to the mixed-lineage leukemia (MLL) family of histone methyltransferases which methylate the histone 3 tail at lysine 4 (H3K4) as part of the complex proteins associated with Set 1 (COMPASS) complex. Although originally identified as oncogenic fusions in leukemia, genome-wide mutation studies have revealed frequent, presumably loss-of-function, mutations in various members of the MLL family, including MLL2/KMT2B, MLL3/KMT2C, and MLL4/KMT2D in a variety of malignancies, particularly solid tumors. Mechanistic studies of KMT2C in normal cells have focused primarily on its role in enhancer regulation by deposition of H3K4me1 marks.